“Telithromycin (Ketek®)in Lower Respiratory Tract Infections: Economic Aspects ”. Farmeconomia. Health Economics and Therapeutic Pathways, vol. 7, no. 2, Sept. 2006, pp. 89-96, https://doi.org/10.7175/fe.v7i2.679.